Caricamento...
Cost-effectiveness analysis review of exemestane in the treatment of primary and advanced breast cancer
INTRODUCTION: Exemestane was approved in 2005 for adjuvant treatment of breast cancer. In this study, we aimed to assess whether it is cost-effective in comparison to available alternatives. MATERIAL AND METHODS: To evaluate the efficacy of exemestane, a systematic review was conducted by searching...
Salvato in:
| Autori principali: | , , , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Termedia Publishing House
2013
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3701982/ https://ncbi.nlm.nih.gov/pubmed/23847669 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5114/aoms.2013.35347 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|